Shigella Test Kit Market to Grow with a CAGR of 6.34% through 2029

Rising Awareness and Healthcare Spending is expected to drive the Global Shigella Test Kit Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “Shigella Test Kit Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global Shigella Test Kit Market stood at USD 106.83 Million in 2023 and is anticipated to grow with a CAGR of 6.34% through 2029. Increased awareness among healthcare professionals and the public about the importance of early detection of infectious diseases like Shigella encourages the uptake of diagnostic tools capable of rapidly and accurately identifying the pathogen. Detecting infections early is critical as it allows for prompt initiation of treatment, which significantly impacts patient outcomes and public health. According to the Canada Medical Association, Canada's total healthcare spending was projected to reach $344 billion in 2023, equating to approximately $8,740 per Canadian and representing about 12.1% of the country's GDP. This places Canada among the highest healthcare spenders within OECD countries. As healthcare spending rises, there is a corresponding demand for advanced diagnostic technologies that offer heightened sensitivity, specificity, and rapid turnaround times. Shigella test kits leveraging molecular techniques such as PCR (Polymerase Chain Reaction) or nucleic acid amplification fulfill these requirements, driving their adoption in clinical settings.

Increased healthcare expenditure often accompanies improvements in healthcare infrastructure, including diagnostic capabilities. Hospitals and diagnostic laboratories equipped with state-of-the-art facilities are more likely to invest in advanced diagnostic technologies like Shigella test kits. These investments aim to enhance diagnostic accuracy and improve patient care outcomes. The combination of heightened awareness about infectious diseases and increased healthcare spending creates a favorable environment for the adoption and expansion of Shigella test kits in healthcare settings. These factors underscore the importance of early detection, effective disease management, and the implementation of public health interventions, all of which contribute to the growth of the Shigella test kit market segment.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " Global Shigella Test Kit Market”

 

Global Shigella Test Kit Market is segmented into test type, technology, end user, regional distribution, and company.

Based on End User, Hospitals emerged as the dominating segment in the global market for Shigella Test Kit in 2023. Hospitals serve as primary healthcare providers where patients with suspected Shigella infections seek diagnosis and treatment. Quick and precise diagnosis is crucial in hospitals to promptly begin appropriate treatment and prevent the spread of infection within healthcare environments. Hospitals cater to a diverse patient population, encompassing individuals with various health conditions and susceptibility to infections. The demand for Shigella test kits in hospitals reflects the necessity to diagnose a wide range of patients presenting with gastrointestinal symptoms, ensuring precise and comprehensive healthcare delivery. Hospitals frequently encounter outbreaks of infectious diseases such as shigellosis. They require dependable diagnostic tools like Shigella test kits to swiftly identify the causative pathogen during outbreaks, implement infection control measures, and effectively manage patient care. Shigella test kits are seamlessly integrated into hospitals' clinical workflows, facilitating smooth diagnostic processes from sample collection to result analysis and reporting. This integration enhances operational efficiency in patient management and contributes to improved overall healthcare outcomes. The pivotal role of hospitals as primary healthcare providers underscores the importance of accessing advanced diagnostic tools capable of delivering rapid and accurate results, thereby supporting optimal patient care and public health initiatives.

Based on Region, the North America region emerged as the dominating region in the global market for Shigella Test Kit in 2023. North America possesses advanced healthcare infrastructure with well-equipped hospitals and diagnostic laboratories capable of adopting and deploying cutting-edge diagnostic technologies, including Shigella test kits. According to estimates from the Centers for Disease Control and Prevention (CDC), approximately 450,000 cases of Shigella infection (shigellosis) occur annually in the United States, with around 242,000 infections being antimicrobial-resistant, posing a significant public health concern. Healthcare providers and the general population in North America exhibit a high level of awareness regarding infectious diseases, underscoring the demand for effective diagnostic tools such as Shigella test kits. North America serves as a prominent center for biomedical research and development, with research institutions and biotechnology firms continuously innovating in diagnostic technologies. These advancements contribute significantly to the evolution of Shigella testing methodologies in the region.

Major companies operating in Global Shigella Test Kit Market are:

• Thermo Fisher Scientific Inc.
• Meridian Bioscience, Inc.
• QIAGEN N.V.
• Diasorin S.p.A.
• Bio-Rad Laboratories Inc.
• BioMérieux SA
• Hygiena LLC
• Molbio Diagnostics Pvt. Ltd.
• Fujirebio Diagnostics, Inc.
• CTK Biotech, Inc.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Shigella test kits utilize advanced molecular technologies such as PCR and antigen detection to achieve exceptional accuracy and efficiency in detecting Shigella bacteria. As awareness of foodborne illnesses grows worldwide and healthcare systems emphasize quick response capabilities, there is a rising demand for these sophisticated diagnostic tools. They not only enable prompt diagnosis and treatment but also significantly contribute to outbreak prevention and enhance public health outcomes on a global scale”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Shigella Test Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Lateral flow assays, Enzyme-linked immunosorbent assay (ELISA), Polymerase chain reaction (PCR) assay, and Others), By Technology (Conventional diagnostic tests, Nucleic acid-based tests, and Others), By End User (Hospitals, Diagnostic laboratories, Research institutes, and Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Shigella Test Kit Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Shigella Test Kit Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com